Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsatile GnRH for Infertility in Non-obese PCOS
NCT03989024Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gonadorelin in polycystic ovary syndrome (PCOS), infertility and ovulation disorder (2 arms), sponsored by Renji Hospital. Primary endpoint: Number of participants with ovulation recovery at 12 weeks. Status: unknown.
02
Drugs
gonadorelin
03
Conditions
polycystic ovary syndrome (PCOS)infertilityovulation disorder
Beyond the preview
Go deeper on NCT03989024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989024.